Authors: Ripple, GH Gould, MN Arzoomanian, RZ Alberti, D Feierabend, C Simon, K Binger, K Tutsch, KD Pomplun, M Wahamaki, M Marnocha, R Wilding, G Bailey, HH

Citation: Gh. Ripple et al., Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day, CLIN CANC R, 6(2), 2000, pp. 390-396

Authors: Robins, HI Tutsch, K Katschinski, DM Jacobson, E Mehta, M Olsen, M Cohen, JD Tiggelaar, CL Arzoomanian, RZ Alberti, D Feierabend, C Wilding, G

Citation: Hi. Robins et al., Phase I trial of intravenous thymidine and carboplatin in patients with advanced cancer, J CL ONCOL, 17(9), 1999, pp. 2922-2931

Authors: Robins, HI Katschinski, DM Longo, W Grosen, E Wilding, G Gillis, W Kraemer, C Tiggelaar, CL Stewart, JA Spriggs, D Arzoomanian, RZ Feierabend, C Alberti, D Morgan, K Simon, K d'Oleire, F

Citation: Hi. Robins et al., A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees Cwhole-body hyperthermia, CANC CHEMOT, 43(5), 1999, pp. 409-414

Authors: Tutsch, KD Arzoomanian, RZ Alberti, D Tombes, MB Feierabend, C Robins, HI Spriggs, DR Wilding, G

Citation: Kd. Tutsch et al., Phase I clinical and pharmacokinetic study of an one-hour infusion of ormaplatin (NSC 363812), INV NEW DR, 17(1), 1999, pp. 63-72